Led by Drug Sales, J&J Posts Solid Third Quarter
October 14, 2014 at 11:00 AM EDT
New drug launches are helping offset tepid consumer and device growth, but competition will likely weigh on the health-care giant next year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.